Advertisement
YOU ARE HERE: LAT HomeCollections

In Brief / HEALTHCARE

J&J, Isis to partner on diabetes drug

September 14, 2007|From Times Wire Reports

Johnson & Johnson will pay Isis Pharmaceuticals Inc. about $275 million to develop two drugs for diabetes, Isis said.

Carlsbad-based Isis will initially receive $45 million, and may be paid $230 million or more for meeting milestones for the as-yet unnamed medicines.

Advertisement
Los Angeles Times Articles
|
|
|